tradingkey.logo

RadNet falls after $103 million all-stock acquisition to buy iCAD

ReutersApr 15, 2025 8:49 PM

Shares of radiology center operator RadNet RDNT.O fall 2% to $52 in extended trading

RDNT says it is acquiring iCAD ICAD.O, an AI breast cancer detection software maker, in an all-stock acquisition valued about $103 million

RDNT is offering $3.61/shr of ICAD common stock, representing a significant 87% premium to ICAD's closing price on Tuesday

Shares of iCAD up 73% at $3.31 in extended trading

Deal expected to close in the second or third quarter of 2025

RDNT says the deal is expected to add over 1,500 healthcare-provider locations across 50 countries to its network

As of last close, RDNT down 24% and ICAD up 5.5%, YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI